Article Details
Retrieved on: 2024-03-14 15:05:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In February, Wuhan Healthgen Biotechnology Corp announced that it had successfully completed phase III clinical trials for plant-derived recombinant ...
Article found on: www.ecns.cn
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here